Location: Home
  • search
  • go
  • Relate News
  • 2/3/2010China Population Association publishes survey findings on breast disea...
  • 2/3/2010Nanomed gains funding from SB China Venture Capital
  • 2/2/2010Chinese government to restructure funding scheme for the national esse...
  • 2/2/2010Guangzhou Huacheng Pharma completes phase III trials of class one cere...
  • 2/2/2010Pharmadule in China business deal with Morimatsu
  • 2/2/2010SinoPharm hopes to become a leading global enterprise
  • 2/2/2010Guangzhou Radio Group acquires controlling stake in publicly-listed Ji...
  • 2/2/2010Covance builds pre-clinical facility near Shanghai
  • 2/1/2010Biocodex and China Medical signs licensing agreement for Bioflor
  • 2/1/2010Achillion licenses its new antiviral drug to GCAT/TPRI for development...
  • 2/1/2010Pfizer wants to be the top generic drug player in Japan
  • 2/1/2010New report urges pharma giants to externalize drug development
  • 2/1/2010GSK to slash up to 4,000 jobs
  • 1/29/2010Gastric Cancer Treatment in China: Significantly Different versus G7 C...
  • 1/29/2010Sanofi-Aventis establishes consumer healthcare JV with Hangzhou Minshe...
  • 1/29/2010Pfizer becomes a leading "biotherapeutics company" f...
  • 1/28/2010Foci Pharma seeks EU market entry for its TCMs through Sweden
  • 1/28/2010Roche awarded "shame" prizes in Davos for CellCept research ...
  • 1/28/2010AstraZeneca sees future sales decline and cuts 8,000 jobs
  • 1/28/2010MOH: public hospital reform to be trialed in 16 cities this year
  • 1/28/2010Novo Nordisk's Victoza under approval process in China
  • 1/28/2010Northeast Pharm makes new investments to diversify business
  • 1/28/2010Roche establishes new medical research hub in Singapore
  • 1/27/2010Pacgen and New Summit Biopharma reach agreement to develop oral candid...
  • 1/27/2010MDRNA receives Chinese patent for use of nucleic acids for cancer trea...
  • 1/27/2010Kangmei Pharma and Jiangzhong Pharma report sharp profit growth in 200...
  • 1/27/2010Pharma e-commerce firm seeks IPO at ChiNext
  • 1/27/2010Novartis launches antihypertensive combination drug Exforge in China ...
  • 1/27/2010Top management reshuffles at Novartis with Vasella stepping down as CE...
  • 1/27/2010Cyntellect expands sales to China and other Asian markets
  • Page:629/774 Total number of articles:23193: [First][<<] [627] [628] [629] [630] [631] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group